Yi Yi Ren (Seeds of Job's Tears)

Chinese Herb Actions

Chinese Herb Dosage

• What is the typical dosage of Yi Yi Ren?

  Roughly 9–30 g in decoction, often used at the higher end of the range given its mild, food-like nature; because it is also a grain it is sometimes cooked as part of the daily diet rather than only decocted.

  • Reference range: 10–30 g in decoction; other materia medica references cite 9–30 g.

  Source: Sacred Lotus sources & references, cross-referenced against multiple online sources. Reference only — not a prescription.

Chinese Herb Contraindications & Cautions

• Is Yi Yi Ren safe during pregnancy?

  Traditional materia medica texts advise caution with Yi Yi Ren in pregnancy, despite its everyday status as a food grain — classical and materia medica sources describe a theoretical uterine-stimulating effect at concentrated, therapeutic (non-culinary) doses, and many practitioners avoid such doses during pregnancy on this basis as a precaution.

  Source: cross-referenced against multiple online sources and standard materia medica texts. Precautionary reference, not a demonstrated clinical risk at ordinary food-level intake.

Chinese Herb Toxicity & Overdose

• Very low. Yi Yi Ren is a staple dietary grain across East and Southeast Asia (also sold as “Job’s tears” or adlay) with an extensive food-safety history; no significant toxicity is reported at normal culinary or decoction doses.

  Source: cross-referenced against multiple online sources and materia medica texts. Reference note, not a safety guarantee.

Herb-Drug Interactions

• No well-established clinical herb–drug interactions are documented for Yi Yi Ren. A coix-seed-oil pharmaceutical extract (Kanglaite injection) is used in China alongside platinum-based chemotherapy for lung cancer (see research) — that is a manufactured, injectable drug product, not evidence of an interaction with the crude herb taken by mouth, but it reflects active clinical interest in combining coix-derived compounds with conventional oncology drugs. (Flagged for practitioner awareness, not a demonstrated oral-herb interaction.)

Western / Biomedical Research

Chinese Herb Clinical Studies & Research

Provided as research context — a summary of published biomedical study, not a therapeutic or medical claim.

• Is there modern research on Yi Yi Ren (Coix lacryma-jobi)?

  Yes — Yi Yi Ren has one of the stronger modern research bases among common Chinese herbs, including human randomized trials of a derived pharmaceutical extract, plus extensive preclinical anti-tumor and metabolic work. A 2024 review catalogs its fatty acids, polysaccharides, sterols, alkaloids, and flavonoids and summarizes reported hypoglycemic, liver-supporting, anti-tumor, gut-microbiota-modulating, Spleen-supporting, and anti-inflammatory activities.

  • Human clinical (adjunct oncology drug) — a meta-analysis of 27 randomized controlled trials found that Kanglaite injection, a coix-seed-oil emulsion, added to platinum-based chemotherapy for stage III/IV non-small-cell lung cancer was associated with improved response and quality-of-life measures versus chemotherapy alone across the pooled trials. This is a manufactured pharmaceutical extract used as a chemotherapy adjunct in Chinese hospitals, not equivalent to eating or decocting the crude seed.
  • Anti-tumor (preclinical, multiple cancer types) — cell and animal studies report that coix-derived lipid and polysaccharide fractions inhibit growth in pancreatic, lung, and liver cancer cell lines via apoptosis and cell-cycle arrest, and one small study reported increases in peripheral cytotoxic T and NK cell counts; laboratory/animal evidence, not a treatment claim for the raw herb.
  • Metabolic and hepatic (preclinical) — reviewed studies report hypoglycemic and liver-function-supporting effects in laboratory and animal models.

  Clinical evidence concentrates on a specific manufactured extract used as an oncology adjunct; evidence for the traditional decocted or food-grade herb itself remains largely preclinical.

  Sources: PMID 37858750 (Coix seed as food and medicinal resource, review, J Ethnopharmacol 2024); PMID 31926475 (Kanglaite injection meta-analysis of 27 RCTs, Phytomedicine 2020); PMID 15955213 (pancreatic cancer cell study, J Gastroenterol Hepatol 2005); PMID 12769541 and PMID 14640580 (lung cancer cell studies, J Agric Food Chem 2003); PMID 12502451 (hepatoma rat model, Zhonghua Gan Zang Bing Za Zhi 2002); PMID 7938271 (antitumor components, Planta Med 1994); PMID 1419467 (immune cell study, Biotherapy 1992). Research context, not a therapeutic claim.

Chinese Herb Notes

• What is the difference between raw and dry-fried (stir-fried) Yi Yi Ren?

  Raw Yi Yi Ren is the stronger damp/damp-heat drainer and pus-expeller, while dry-fried (stir-fried) Yi Yi Ren is gentler and better suited to strengthening a deficient Spleen and stopping diarrhea — the same herb, processed differently for two different presentations.

  • Raw — favored for damp-heat, edema, abscess/pus, and skin lesions such as verrucae, where its cooler, more strongly draining quality is wanted.
  • Dry-fried — the frying process mellows its cold, draining nature, making it better tolerated for a weak, loose-stool Spleen-deficient presentation without a significant heat component.

  How is Yi Yi Ren different from Fu Ling?

  Both drain dampness while strengthening the Spleen, but Yi Yi Ren also clears heat and expels pus, while Fu Ling additionally calms the Heart/spirit. Yi Yi Ren is chosen when damp-heat or abscess/pus is part of the picture; Fu Ling when the goal is broader Spleen support with a mild calming benefit.

  Source: cross-referenced against multiple online sources and standard materia medica texts.